A novel model for Ki67 assessment in breast cancer

[1]  G. Viale,et al.  The current state of breast cancer classification. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  D C McMillan,et al.  Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer , 2012, British Journal of Cancer.

[3]  V. Cooper.  Diagnostic pathology. , 2012, The Veterinary clinics of North America. Food animal practice.

[4]  P. Bendahl,et al.  P1-07-16: Number Needed To Count: A Novel Model for Ki67 Assessment in Breast Cancer. , 2011 .

[5]  Jack Cuzick,et al.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. , 2011, Journal of the National Cancer Institute.

[6]  G. Viale.  Pathological work up of the primary tumor: getting the proper information out of it. , 2011, Breast.

[7]  Christian Ingvar,et al.  Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies , 2011, BMC Cancer.

[8]  E Leonardi,et al.  Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies , 2011, Diagnostic pathology.

[9]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[10]  Mitch Dowsett,et al.  Current and emerging biomarkers in breast cancer: prognosis and prediction. , 2010, Endocrine-related cancer.

[11]  K. Gelmon,et al.  Ki67 in breast cancer: prognostic and predictive potential. , 2010, The Lancet. Oncology.

[12]  G. Kayser,et al.  Theory of sampling and its application in tissue based diagnosis , 2009, Diagnostic pathology.

[13]  C Caldas,et al.  Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. , 2008, Breast.

[14]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  G Hüttmann,et al.  Chromophore‐assisted light inactivation of pKi‐67 leads to inhibition of ribosomal RNA synthesis , 2007, Cell proliferation.

[16]  C. Sotiriou,et al.  Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients , 2007, British Journal of Cancer.

[17]  Johannes Gerdes,et al.  Ki‐67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells , 2006, Journal of cellular physiology.

[18]  Mitch Dowsett,et al.  Proliferation marker Ki-67 in early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  W. McGuire,et al.  Why do so many prognostic factors fail to pan out? , 2005, Breast Cancer Research and Treatment.

[20]  J. Baak,et al.  Prognostic value of proliferation in invasive breast cancer: a review , 2004, Journal of Clinical Pathology.

[21]  Lajos Pusztai,et al.  Breast cancer biomarkers and molecular medicine , 2003, Expert review of molecular diagnostics.

[22]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[23]  A. Thor,et al.  Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Boon.  Microwave-antigen retrieval: the importance of pH of the retrieval solution for MIB-1 staining. , 1996, European journal of morphology.

[25]  P. Hall,et al.  The relevance of antibody concentration to the immunohistological quantification of cell proliferation‐associated antigens , 1993, Histopathology.

[26]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.

[27]  F. Lacombe,et al.  Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. , 1991, Cytometry.

[28]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[29]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.